Supports capital-efficient expansion of the SLS009 clinical program into frontline AML, enabling broader U.S. and European patient enrollment ...
The industry regulator has sanctioned three broker-dealers in the Cetera network for weak controls around low-priced securities and customer reporting.
The Trump Administration has prioritized deregulation, aiming to reduce compliance costs under the Bank Secrecy Act (BSA).
Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.
AllAfrica on MSN
Liberia: AML's Deal Is On
Liberian President Joseph N. Boakai has formally requested the Liberian Senate to amend the third Mineral Development Agreement (MDA) between the Government of Liberia and ArcelorMittal Liberia ...
Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated AML – – $2.1 million ...
SmartSearch has completed its acquisition of Cardiff-based legal and property sector identity verification provider Credas ...
AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and ...
2don MSN
Is 2026 the Year Block Rebounds?
After a brutal 26% decline in 2025, Block ( XYZ 0.79%) has begun to regain ground in early 2026. Even so, investors appear ...
India’s FIU has rolled out new crypto rules mandating PAN, selfie liveness checks, and compliance officers for all exchanges ...
Stocktwits on MSN
SLS stock in spotlight on EU expansion for cancer therapy – retail says potential catalyst for buyout
The European study is expected to enroll 40 newly diagnosed AML patients. ・Enrollment at U.S. sites is planned to begin in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results